Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Vipul Jairath"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 10, Pp 2482-2490 (2019)
Vedolizumab is a monoclonal antibody to the α4β7 integrin that selectively reduces intestinal lymphocyte trafficking, thereby providing a safe and effective treatment option for patients with inflammatory bowel disease (IBD). This product review ou
Externí odkaz:
https://doaj.org/article/5375fc85c13d434c820dccc6752b36d7